Molecular ontogeny of the human antibody repertoire to the Haemophilus influenzae type B polysaccharide : expression of canonical variable regions and their variants in vaccinated infants

A structurally conserved antibody combining site, encoded by the IGH V3-23 and kappa A2 variable (V) region gene segments, predominates the adult immune response to the Haemophilus influenzae type b (Hib) capsular polysaccharide (PS). This site has been elevated to canonical status based upon its re...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 108(2003), 2 vom: 15. Aug., Seite 119-27
1. Verfasser: Lucas, Alexander H (VerfasserIn)
Weitere Verfasser: McLean, Gary R, Reason, Donald C, O'Connor, Adam P, Felton, Mistique C, Moulton, Karen D
Format: Aufsatz
Sprache:English
Veröffentlicht: 2003
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. Antibodies, Anti-Idiotypic Antibodies, Bacterial Bacterial Proteins Haemophilus Vaccines Immunoglobulin Fab Fragments Immunoglobulin Heavy Chains Immunoglobulin Light Chains mehr... Immunoglobulin Variable Region Polysaccharides, Bacterial Vaccines, Synthetic HibTITER protein, Haemophilus influenzae 126161-67-9
LEADER 01000naa a22002652 4500
001 NLM126744734
003 DE-627
005 20231222212524.0
007 tu
008 231222s2003 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0423.xml 
035 |a (DE-627)NLM126744734 
035 |a (NLM)12921758 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Lucas, Alexander H  |e verfasserin  |4 aut 
245 1 0 |a Molecular ontogeny of the human antibody repertoire to the Haemophilus influenzae type B polysaccharide  |b expression of canonical variable regions and their variants in vaccinated infants 
264 1 |c 2003 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 01.10.2003 
500 |a Date Revised 07.11.2019 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a A structurally conserved antibody combining site, encoded by the IGH V3-23 and kappa A2 variable (V) region gene segments, predominates the adult immune response to the Haemophilus influenzae type b (Hib) capsular polysaccharide (PS). This site has been elevated to canonical status based upon its relative molecular uniformity and prevalence in adults. To date, no studies have examined the primary structure of Hib PS-specific antibodies in young infants, who are the primary targets of Hib vaccination. In this study we show that canonical Hib PS-specific heavy (H) and light (L) chain V regions are present in 4-month-old infants following two vaccinations with Hib PS-protein conjugates. The infant V regions contain sequence polymorphisms that resemble those found in adult antibodies, as well as polymorphisms at position 95a of the A2 L chain not previously observed in adults. In vitro studies of Fab fragments and recombinant IgG2 antibodies using these V regions identify sequence polymorphisms that impact Hib PS binding affinity and bactericidal activity. These results demonstrate the establishment of canonical V regions in early ontogeny and provide a structural explanation of how canonical antibodies in the infant can vary in their affinity and protective activity against Hib 
650 4 |a Comparative Study 
650 4 |a Journal Article 
650 4 |a Research Support, U.S. Gov't, P.H.S. 
650 7 |a Antibodies, Anti-Idiotypic  |2 NLM 
650 7 |a Antibodies, Bacterial  |2 NLM 
650 7 |a Bacterial Proteins  |2 NLM 
650 7 |a Haemophilus Vaccines  |2 NLM 
650 7 |a Immunoglobulin Fab Fragments  |2 NLM 
650 7 |a Immunoglobulin Heavy Chains  |2 NLM 
650 7 |a Immunoglobulin Light Chains  |2 NLM 
650 7 |a Immunoglobulin Variable Region  |2 NLM 
650 7 |a Polysaccharides, Bacterial  |2 NLM 
650 7 |a Vaccines, Synthetic  |2 NLM 
650 7 |a HibTITER protein, Haemophilus influenzae  |2 NLM 
650 7 |a 126161-67-9  |2 NLM 
700 1 |a McLean, Gary R  |e verfasserin  |4 aut 
700 1 |a Reason, Donald C  |e verfasserin  |4 aut 
700 1 |a O'Connor, Adam P  |e verfasserin  |4 aut 
700 1 |a Felton, Mistique C  |e verfasserin  |4 aut 
700 1 |a Moulton, Karen D  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 108(2003), 2 vom: 15. Aug., Seite 119-27  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:108  |g year:2003  |g number:2  |g day:15  |g month:08  |g pages:119-27 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 108  |j 2003  |e 2  |b 15  |c 08  |h 119-27